Androclus Therapeutics Announces Patent For Heat Shock Protein Derived Peptides Licensed From University Of California

SAN DIEGO--(BUSINESS WIRE)--Feb. 7, 2006--Androclus Therapeutics announced that a U.S. Patent No. 6,989,146 entitled “Stress Proteins and Peptides and Methods of Use Thereof” was granted on January 24, 2006. The inventors are Dr. Salvatore Albani and Dr. Berent Prakken. The patent is assigned to the University of California and has been exclusively licensed to Androclus Therapeutics.

MORE ON THIS TOPIC